Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation in three upcoming investor conferences in September 2025. The company's management will engage in webcast fireside chats at the Wells Fargo Healthcare Conference (September 3 at 8:45 a.m. ET), Cantor Global Healthcare Conference (September 4 at 8:35 a.m. ET), and Baird Global Healthcare Conference (September 9 at 10:15 a.m. ET).

All webcasts will be accessible through the company's website under the "Events and Presentations" page, with replays available for approximately 30 days after each event.

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences:

Wells Fargo Healthcare Conference
Date/Time: Wednesday, September 3, 2025 at 8:45 a.m. ET

Cantor Global Healthcare Conference
Date/Time: Thursday, September 4, 2025 at 8:35 a.m. ET

Baird Global Healthcare Conference
Date/Time: Tuesday, September 9, 2025 at 10:15 a.m. ET

The live conference webcasts will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 30 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.

Investor Contact: 
Eva Stroynowski
eva.stroynowski@apellis.com
617.938.6229

FAQ

When is Apellis Pharmaceuticals (APLS) presenting at the Wells Fargo Healthcare Conference 2025?

Apellis will present at the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 8:45 a.m. ET.

How can investors access Apellis Pharmaceuticals' (APLS) conference presentations in September 2025?

Investors can access the live webcasts through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website. Replays will be available for approximately 30 days after each event.

Which investor conferences is Apellis Pharmaceuticals (APLS) attending in September 2025?

Apellis is participating in three conferences: the Wells Fargo Healthcare Conference (Sept 3), Cantor Global Healthcare Conference (Sept 4), and Baird Global Healthcare Conference (Sept 9).

How long will the replays of Apellis Pharmaceuticals' (APLS) conference webcasts be available?

The replays of the conference webcasts will be available for approximately 30 days following each event.